Genitourinary Syndrome – Causes, Symptoms and Treatment
Genitourinary syndrome refers to a range of symptoms affecting the urinary and genital organs, most commonly caused by declining estrogen levels during menopause.
Things worth knowing about "Genitourinary Syndrome"
Genitourinary syndrome refers to a range of symptoms affecting the urinary and genital organs, most commonly caused by declining estrogen levels during menopause.
What Is Genitourinary Syndrome?
Genitourinary Syndrome of Menopause (GSM) – formerly known as vulvovaginal atrophy or urogenital atrophy – is a medical condition that encompasses a broad range of symptoms and physical changes affecting the vagina, vulva, urethra, and bladder. These changes occur primarily due to a decline in estrogen levels, most commonly associated with the natural transition of menopause, but also triggered by other hormonal alterations.
As estrogen levels fall, the tissues of the urogenital area become thinner, drier, less lubricated, and less elastic. This process significantly impacts quality of life and is experienced by a large proportion of postmenopausal women, though it is often underreported due to embarrassment or lack of awareness.
Causes
The primary cause of genitourinary syndrome is reduced estrogen production. Contributing causes include:
- Natural menopause
- Surgical removal of the ovaries (bilateral oophorectomy)
- Chemotherapy or pelvic radiation therapy
- Anti-estrogen medications used in breast cancer treatment (e.g., aromatase inhibitors, tamoxifen)
- Breastfeeding (temporary estrogen suppression)
- Primary ovarian insufficiency
Symptoms
Genitourinary syndrome presents with a wide range of vaginal, vulvar, and urinary symptoms:
Vaginal and Vulvar Symptoms
- Vaginal dryness – the most commonly reported symptom
- Burning, itching, and irritation of the vulva
- Pain during sexual intercourse (dyspareunia)
- Reduced vaginal lubrication during sexual activity
- Light bleeding after intercourse
Urinary Symptoms
- Increased urinary frequency (pollakiuria)
- Urgency with involuntary urine leakage (urge incontinence)
- Burning or discomfort during urination (dysuria)
- Recurrent urinary tract infections
Diagnosis
Diagnosis is typically made by a gynecologist or urologist and is based on:
- A thorough medical history and symptom assessment
- Physical examination of the vulva, vagina, and urethra
- Vaginal pH testing (elevated pH indicates reduced estrogen activity)
- Vaginal cytology (a swab to assess tissue changes)
- Blood hormone level testing when indicated
Treatment
Several effective treatment options are available. The choice depends on the severity of symptoms, the presence of other menopausal symptoms, and the individual patient's health profile and preferences:
Local (Topical) Therapy
- Vaginal estrogen preparations (creams, suppositories, rings, or tablets): Considered the gold standard for treating GSM. They act directly on affected tissues with minimal systemic absorption and are generally safe even for women with a history of breast cancer (under medical supervision).
- Vaginal moisturizers and lubricants: Non-hormonal options that relieve dryness and discomfort. Suitable for women who cannot or prefer not to use hormonal therapy.
- Ospemifene: An oral selective estrogen receptor modulator (SERM) approved for moderate to severe dyspareunia associated with GSM.
Systemic Therapy
- Hormone replacement therapy (HRT): Systemic estrogen (alone or combined with progestogen) may be appropriate for women experiencing both GSM and other menopausal symptoms such as hot flashes. Benefits and risks should be carefully evaluated on an individual basis.
Non-Pharmacological Approaches
- Regular sexual activity or use of vaginal dilators to maintain tissue elasticity and blood flow
- Avoiding irritants such as scented soaps, douches, and synthetic underwear
- Pelvic floor exercises (Kegel exercises) to strengthen supporting muscles and reduce urinary symptoms
Prognosis and Outlook
Without treatment, genitourinary syndrome tends to be progressive and worsening over time. However, with appropriate treatment, symptoms can be substantially reduced and quality of life significantly improved. Early intervention helps prevent further tissue changes. Women are encouraged to openly discuss these symptoms with their healthcare provider, as the condition remains widely underdiagnosed and undertreated.
References
- Portman DJ, Gass ML; Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Menopause. 2014;21(10):1063-1068.
- Nappi RE, Kokot-Kierepa M. Vaginal Health: Insights, Views & Attitudes (VIVA) – results from an international survey. Climacteric. 2012;15(1):36-44.
- Krychman ML. Vaginal estrogens for the treatment of dyspareunia. Journal of Sexual Medicine. 2011;8(3):666-674.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryTissue Hormone Balance
Chitin degradation
Self-esteem
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Genitourinary Syndrome-en